Full enrollment in cutaneous melanoma dose-expansion arms of Phase 1/1b clinical trial evaluating WTX-124 as monotherapy and ...
North Texas health officials said they are keeping a close eye on the spread in outbreak communities and have plans in place ...
Sunday looks to be the beginning of a warming trend in West Central Texas. St. Patrick's Day Monday we look to have highs in ...
Reports Q4 revenue $0 vs. $301,590. “Werewolf made considerable progress in 2024 with promising preliminary evidence of durable anti-tumor ...
Werewolf Therapeutics provided a business update, announcing progress in their clinical trials for WTX-124, a conditionally activated therapeutic for cutaneous melanoma, with full enrollment in ...
Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 ...
Odessa-Midland KOSA-TV on MSN4mon
Midland Chamber of Commerce host 4th Annual WTX Women’s SymposiumThe Midland Chamber of Commerce hosted their 4th Annual WTX Women’s Symposium. The event is designed to empower women in ...
Full enrollment in cutaneous melanoma dose-expansion arms of Phase 1/1b clinical trial evaluating WTX-124 as monotherapy and in combination with pembrolizumab expected by the end of the first half ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback